These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review]. Verdecchia P G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978 [No Abstract] [Full Text] [Related]
10. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct]. Rühle H Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541 [No Abstract] [Full Text] [Related]
11. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents]. Bousser MG J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet and anticoagulant therapy in acute myocardial infarction. Jafri SM Henry Ford Hosp Med J; 1991; 39(3-4):195-9. PubMed ID: 1804824 [No Abstract] [Full Text] [Related]
13. [Present situation of therapy with platelet aggregation inhibitors]. Poliwoda H Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157 [No Abstract] [Full Text] [Related]
14. Effect of drugs of platelets and complications of vascular disease. Mustard JF; Packham MA; Kinlough-Rathbone RL Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448 [No Abstract] [Full Text] [Related]
15. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders]. Thiele R Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068 [No Abstract] [Full Text] [Related]